HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ustekinumab therapy for severe interstitial granulomatous dermatitis with arthritis.

AuthorsPauline Leloup, Hélène Aubert, Sylvie Causse, Benoît Le Goff, Sébastien Barbarot
JournalJAMA dermatology (JAMA Dermatol) Vol. 149 Issue 5 Pg. 626-7 (May 2013) ISSN: 2168-6084 [Electronic] United States
PMID23677104 (Publication Type: Case Reports, Letter)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal, Humanized
  • Ustekinumab
Topics
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Antibodies, Monoclonal, Humanized (therapeutic use)
  • Arthritis, Rheumatoid (complications)
  • Dermatitis (complications, drug therapy, pathology)
  • Granuloma (complications, drug therapy, pathology)
  • Humans
  • Male
  • Middle Aged
  • Skin Diseases (complications, drug therapy, pathology)
  • Ustekinumab

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: